Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 99
Filter
1.
Arq. bras. cardiol ; 117(2): 423-423, ago. 2021.
Article in Portuguese | LILACS | ID: biblio-1339165
2.
Clinics ; 72(8): 474-480, Aug. 2017. tab
Article in English | LILACS | ID: biblio-890719

ABSTRACT

OBJECTIVE: Using magnetic resonance imaging, we aimed to assess the presence of silent brain vascular lesions in a sample of apparently healthy elderly individuals who were recruited from an economically disadvantaged urban region (São Paulo, Brazil). We also wished to investigate whether the findings were associated with worse cognitive performance. METHODS: A sample of 250 elderly subjects (66-75 years) without dementia or neuropsychiatric disorders were recruited from predefined census sectors of an economically disadvantaged area of Sao Paulo and received structural magnetic resonance imaging scans and cognitive testing. A high proportion of individuals had very low levels of education (4 years or less, n=185; 21 with no formal education). RESULTS: The prevalence of at least one silent vascular-related cortical or subcortical lesion was 22.8% (95% confidence interval, 17.7-28.5), and the basal ganglia was the most frequently affected site (63.14% of cases). The subgroup with brain infarcts presented significantly lower levels of education than the subgroup with no brain lesions as well as significantly worse current performance in cognitive test domains, including memory and attention (p<0.002). CONCLUSIONS: Silent brain infarcts were present at a substantially high frequency in our elderly sample from an economically disadvantaged urban region and were significantly more prevalent in subjects with lower levels of education. Covert cerebrovascular disease significantly contributes to cognitive deficits, and in the absence of magnetic resonance imaging data, this cognitive impairment may be considered simply related to ageing. Emphatic attention should be paid to potentially deleterious effects of vascular brain lesions in poorly educated elderly individuals from economically disadvantaged environments.


Subject(s)
Humans , Male , Female , Aged , Brain Infarction/complications , Brain Infarction/epidemiology , Asymptomatic Diseases/epidemiology , Cognitive Dysfunction/etiology , Cognitive Dysfunction/epidemiology , Psychiatric Status Rating Scales , Reference Values , Socioeconomic Factors , Brazil/epidemiology , Magnetic Resonance Imaging , Prevalence , Risk Factors , Analysis of Variance , Age Factors , Risk Assessment , Brain Infarction/physiopathology , Cognitive Dysfunction/physiopathology , Intelligence Tests , Neuropsychological Tests
3.
Arq. bras. cardiol ; 109(2): 103-109, Aug. 2017. tab
Article in English | LILACS | ID: biblio-887907

ABSTRACT

Abstract Background: Depressive symptoms are independently associated with an increased risk of cardiovascular disease (CVD) among individuals with non-diagnosed CVD. The mechanisms underlying this association, however, remain unclear. Inflammation has been indicated as a possible mechanistic link between depression and CVD. Objectives: This study evaluated the association between persistent depressive symptoms and the onset of low-grade inflammation. Methods: From a database of 1,508 young (mean age: 41 years) individuals with no CVD diagnosis who underwent at least two routine health evaluations, 134 had persistent depressive symptoms (Beck Depression Inventory - BDI ≥ 10, BDI+) and 1,374 had negative symptoms at both time points (BDI-). All participants had been submitted to repeated clinical and laboratory evaluations at a regular follow-up with an average of 26 months from baseline. Low-grade inflammation was defined as plasma high-sensitivity C-Reactive Protein (CRP) concentrations > 3 mg/L. The outcome was the incidence of low-grade inflammation evaluated by the time of the second clinical evaluation. Results: The incidence of low-grade inflammation was more frequently observed in the BDI+ group compared to the BDI- group (20.9% vs. 11.4%; p = 0.001). After adjusting for sex, age, waist circumference, body mass index, levels of physical activity, smoking, and prevalence of metabolic syndrome, persistent depressive symptoms remained an independent predictor of low-grade inflammation onset (OR = 1.76; 95% CI: 1.03-3.02; p = 0.04). Conclusions: Persistent depressive symptoms were independently associated with low-grade inflammation onset among healthy individuals.


Resumo Fundamento: Sintomas depressivos estão associados de forma independente ao risco aumentado de doença cardiovascular (DCV) em indivíduos com DCV não diagnosticada. Os mecanismos subjacentes a essa associação, entretanto, não estão claros. Inflamação tem sido indicada como um possível elo mecanicista entre depressão e DCV. Objetivos: Este estudo avaliou a associação entre sintomas depressivos persistentes e o início de inflamação de baixo grau. Métodos: De um banco de dados de 1.508 indivíduos jovens (idade média: 41 anos) sem diagnóstico de DCV submetidos a pelo menos duas avaliações de saúde de rotina, 134 tinham sintomas depressivos persistentes (Inventário de Depressão de Beck - BDI ≥10, BDI+) e 1.374 não apresentavam sintomas em nenhuma das ocasiões (BDI-). Todos os participantes foram submetidos a repetidas avaliações clínicas e laboratoriais em seguimento regular, cuja média foi de 26 meses desde a condição basal. Definiu-se inflamação de baixo grau como concentração plasmática de proteína C reativa (PCR) ultrassensível > 3 mg/L. O desfecho foi a incidência de inflamação de baixo grau por ocasião da segunda avaliação clínica. Resultados: A incidência de inflamação de baixo grau foi maior no grupo BDI+ em comparação ao grupo BDI- (20,9% vs. 11,4%; p = 0,001). Após ajuste para sexo, idade, circunferência abdominal, índice de massa corporal, níveis de atividade física, tabagismo e prevalência de síndrome metabólica, os sintomas depressivos persistentes continuaram sendo um preditor independente de início de inflamação de baixo grau (OR = 1,76; IC 95%: 1,03-3,02; p = 0,04). Conclusões: Sintomas depressivos persistentes foram independentemente associados com início de inflamação de baixo grau em indivíduos saudáveis.

4.
Einstein (Säo Paulo) ; 13(3): 454-461, July-Sep. 2015. tab, graf
Article in English | LILACS | ID: lil-761960

ABSTRACT

Non-ST segment elevation coronary syndrome usually results from instability of an atherosclerotic plaque, with subsequent activation of platelets and several coagulation factors. Its treatment aims to reduce the ischemic pain, limiting myocardial damage and decreasing mortality. Several antiplatelet and anticoagulation agents have been proven useful, and new drugs have been added to the therapeutic armamentarium in the search for higher anti-ischemic efficacy and lower bleeding rates. Despite the advances, the mortality, infarction and readmission rates remain high.


A síndrome coronária sem supradesnivelamento do ST geralmente resulta da instabilização de uma placa aterosclerótica, com subsequente ativação plaquetária e de diversos fatores de coagulação. O tratamento visa aliviar a dor isquêmica, limitar o dano miocárdico e diminuir a mortalidade. Diversos agentes antiagregantes e anticoagulantes provaram sua utilidade, e novas drogas passaram a compor o arsenal terapêutico, buscando maior eficácia anti-isquêmica e menores índices de sangramento. Apesar dos avanços, as taxas de mortalidade, infarto e reinternação ainda permanecem elevadas.


Subject(s)
Humans , Acute Coronary Syndrome/drug therapy , Angina, Unstable/drug therapy , Critical Care , Myocardial Infarction/drug therapy , Acute Coronary Syndrome/diagnosis , Angina, Unstable/diagnosis , Anticoagulants/therapeutic use , Cineangiography , Evidence-Based Medicine/methods , Myocardial Infarction/diagnosis , Platelet Aggregation Inhibitors/therapeutic use
5.
Arq. bras. cardiol ; 104(6): 443-449, 06/2015. tab
Article in English | LILACS | ID: lil-750700

ABSTRACT

Background: The aging process promotes a progressive increase in chronic-degenerative diseases. The effect of these diseases on the functional capacity has been well recognized. Another health parameter concerns “quality of life related to health”. Among the elderly population, cardiovascular diseases stand out due to the epidemiological and clinical impact. Usually, these diseases have been associated with others. This set of problems may compromise both independence and quality of life in elderly patients who seek cardiologic treatment. These health parameters have not been well contemplated by cardiologists. Objective: Evaluating, among the elderly population with cardiovascular disease, which are the most relevant clinical determinants regarding dependence and quality of life. Methods: This group was randomly and consecutively selected and four questionnaires were applied: HAQ, SF-36, PRIME-MD e Mini Mental State. Results: The study included 1,020 elderly patients, 63.3% women. The group had been between 60 and 97 years-old (mean: 75.56 ± 6.62 years-old). 61.4% were independent or mild dependence. The quality of life total score was high (HAQ: 88.66 ± 2.68). 87.8% of patients had a SF-36 total score > 66. In the multivariate analysis, the association between diagnoses and high degrees of dependence was significant only for previous stroke (p = 0.014), obesity (p < 0.001), lack of physical activity (p = 0.016), osteoarthritis (p < 0.001), cognitive impairment (p < 0.001), and major depression (p < 0.001). Analyzing the quality of life, major depression and physical illness for depression was significantly associated with all domains of the SF-36. Conclusion: Among an elderly outpatient cardiology population, dependence and quality of life clinical determinants are not cardiovascular comorbidities, especially the depression. .


Fundamento: Com o envelhecimento, a prevalência de doenças crônico-degenerativas sofreu aumento progressivo. A repercussão dessas doenças sobre a capacidade funcional foi reconhecida. Outro parâmetro de saúde é a “qualidade de vida relacionada à saúde”. Na população idosa, as doenças cardiovasculares destacam-se pelo impacto epidemiológico e clínico. Elas, geralmente, vêm associadas a outras afecções. Esse conjunto de problemas pode comprometer a independência e a qualidade de vida do idoso que busca tratamento cardiológico. Objetivo: Avaliar, em uma população de idosos cardiopatas, quais são os determinantes clínicos mais relevantes de dependência e de qualidade de vida. Métodos: O grupo foi selecionado aleatória e consecutivamente, sendo aplicados quatro questionários: HAQ, SF-36, PRIME‑MD e Mini Exame do Estado Mental. Resultados: Incluiu-se 1020 idosos, 63,3% mulheres. O grupo tinha em média 75,56 ± 6,62 anos. 61,4% mostrou-se independente ou com dependência leve. O escore de qualidade de vida foi elevado (HAQ: 88,66 ± 2,68). 87,8% dos pacientes apresentou escore total do SF-36 ≥ 66. À análise multivariada, a associação entre os diagnósticos e graus elevados de dependência foi significante apenas para acidente vascular cerebral prévio (p = 0,014), obesidade (p < 0,001), sedentarismo (p = 0,016), osteoartrite (p < 0,001), déficit cognitivo (p < 0,001), e depressão maior (p < 0,001). Ao analisarmos a qualidade de vida, a depressão maior e a depressão por doença física associou-se significativamente com todos os domínios do SF-36. Conclusão: Em uma população de idosos cardiopatas, os determinantes clínicos mais relevantes de prejuízos para dependência e qualidade de vida foram as comorbidades não cardiovasculares, particularmente a depressão. .


Subject(s)
Humans , Hepatocytes/pathology , Liver Regeneration , Liver Failure, Acute/metabolism , Apoptosis , /physiology , Fas Ligand Protein/physiology , Hepatocytes/metabolism , Liver Failure, Acute/therapy , Necrosis , Receptors, Tumor Necrosis Factor/metabolism , Signal Transduction , TNF-Related Apoptosis-Inducing Ligand/physiology , Tumor Necrosis Factor-alpha/metabolism
8.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 23(2): 28-34, abr.-jun. 2013. tab, graf
Article in Portuguese | LILACS | ID: lil-724439

ABSTRACT

A falta de aderência às orientações e tratamentos dos pacientes com doenças cardiovasculares é extremamente prevalente e se associa a maior morbidade, mortalidade e custos em saúde. Controle pressórico inadequado nos hipertensos, maior mortalidade nos pacientes que realizaram angioplastia e necessidade de reinternação em pacientes com insuficiência cardíaca são algumas das consequências associadas à má aderência. Diversos fatores estão implicados, como complexidade do regime terapêutico, custos, efeitos adversos, falta de acesso ao sistema de saúde, comunicação inadequada, baixos níveis de conhecimento em saúde e presença de depressão ou déficit cognitivo. Não existe padrão ouro para mensurar os níveis de aderência e foram utilizados autorrelatos, contagem de comprimidos, embalagens eletrônicas, renovação de receitas em sistemas fechados de farmácia e níveis séricos de medicação. Para melhora deste cenário, precisamos implementar efetivamente os conhecimentos existentes e desenvolver novas estratégias de intervenção. Diminuição do custo d drogas, simplificação de esquemas posológicos, comunicação adequada e estratégias comportamentais que incorporam o uso de medicações e comportamentos mais saudáveis no dia-a-dia dos pacientes obtiveram sucesso em estudos clínicos.


The lack of adherence to guidelines and treatment of patients with cardiovascular disease in highly prevalente and is associated with increased morbidity, mortality and healthcare costs. Inadequate blood pressure control in hypertensive patients, increased mortality in patients undergoing angioplasty and need for re-hospitalization in patients with heart failure are some of the consequences associated with poor adherence. Several factors are implicated as therapeutic regimen complexity, cost, adverse effects, lack of access to health care, inadequate communication, low levels of knowledge about health and presence of depression or cognitive impairment. There is no gold standard for measuring levels of adherence. Therefore self-reports, pill counts, electronic packaging, prescription refills in closed pharmacy system and sérum levels of medications were used for measuring levels of adherence. To improve this scenario, we need to effectively implemente existing knowledge and developed new strategies for intervention. Decreased drug cost, simplified dosing regimens, proper communication and behavioral strategies that incorporated the use of medications and healthy behaviors in the daily lives of patients were successful in clinical trials.


Subject(s)
Humans , Medication Adherence/psychology , Cardiovascular Diseases/etiology , Health Literacy , Antihypertensive Agents/therapeutic use , Hypertension/complications , Surveys and Questionnaires , Risk Factors
9.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 23(2): 40-45, abr.-jun. 2013.
Article in Portuguese | LILACS | ID: lil-724441

ABSTRACT

Vivemos um momento de transição radical na área da saúde. Com novos modelos de saúde, a atenção é entregue por equipes, avaliada pelos resultados e adquirida como pacotes. Nesta nova configuração, mídias digitais e sociais tornam-se uma fonte cada vez mais importante de valor. As pessoa estão sendo capacitadas a participar mais ativamente de sua própria saúde, fornecendo novas ferramentas para gerenciar as condições crônicas e aliviar a carga sobre os sobrecarregados sistemas de saúde. A saúde é prestada, tradicionalmente, em três espaços: domicílios, clínicas e hospitais. As mídias digitais criaram o quarto espaço, o espaço digital, que inclui: canal digital para saúde, inovação digital e iniciativas digitais de impacto social. No canal digital para saúde, os profissionais de saúde estão implantando mídia digital e social no sistema de saúde tradicional para, por exemplo, consulta de acompanhamento por e-mail e acesso on-line para os resultados de laboratório. Na área de inovação digital para consumidores, mídia digital e social oferecem maneiras novas e melhores para pacientes e cuidadores gerirem doença e saúde e compartilharem experiências com comunidade on-line. Nas iniciativas digitais de impacto social, as organizações dos setores público e privado usam inovações digitais para facilitar comunicações interativas, a fim de prevenir a doença e promover a saúde. Concluindo, o uso das estratégias digitais na área da saúde está cada vez mais presente e, certamente, contribui e contribuirá para a melhoria da prática clínica, porém, ainda se sugere a necessidade de novos estudos bem planejados e de qualidade sobre este novo método.


We are living a moment of a radical transition in the health area. Health care is proportioned by a team, evaluated by results and acquired like packets. In this new way of health care the digital and social media become na important source of value. People are being capable of taking part actively of their own health, providing tools to manage chronic conditions in order to relieve "overburdened" health system. The health traditionally contains three spaces: homes, ambulatories and hospitals. The digital media created the fourth space, the digital space that includes: digital channel for health, digital innovation and digital initiatives of social impact. In the digital channel for health, the health professional are implanting digital and social media in the traditional health system to make the follow up of patients by e-mail, or to have online access of laboratory results. In the digital innovation for consumers social and digital media provide new and better ways for patients and caregivers to manage disease and health and share experiences with online community. In the digital initiatives of social impact, the private and public organizations to prevent disease and promote health. Concluding, the use of digital strategies in the health area is more and more presente and certainly contributes and will contribute to improve clinical practice, however we suggest the need of well-planned new studies for the use of this strategy.


Subject(s)
Humans , Cardiovascular Diseases/prevention & control , Social Media , Health Promotion/methods , Diffusion of Innovation , Internet , Health Personnel/trends , Telemedicine
11.
Clinics ; 67(4): 305-311, 2012. ilus, tab
Article in English | LILACS | ID: lil-623108

ABSTRACT

OBJECTIVES: Though elderly persons with chronic atrial fibrillation have more comorbidities that could limit indications for the chronic use of anticoagulants, few studies have focused on the risk of falls within this particular group. To evaluate the predictors of the risk of falls among elderly with chronic atrial fibrillation, a cross-sectional, observational study was performed. METHODS: From 295 consecutive patients aged 60 years or older with a history of atrial fibrillation who were enrolled within the last 2 years in the cardiogeriatrics outpatient clinic of the Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, 107 took part in this study. Their age was 77.9±6.4 years, and 62 were female. They were divided into two groups: a) no history of falls in the previous year and b) a history of one or more falls in the previous year. Data regarding the history of falls and social, demographic, anthropometric, and clinical information were collected. Multidimensional assessment instruments and questionnaires were applied. RESULTS: At least one fall was reported in 55 patients (51.4%). Among them, 27 (49.1%) presented recurrent falls, with body lesions in 90.4% and fractures in 9.1% of the cases. Multivariate logistic regression showed that selfreported difficulty maintaining balance, use of amiodarone, and diabetes were independent variables associated with the risk of falls, with a sensitivity of 92.9% and a specificity of 44.9%. CONCLUSION: In a group of elderly patients with chronic atrial fibrillation who were relatively independent and able to attend an outpatient clinic, the occurrence of falls with recurrence and clinical consequences was high. Difficulty maintaining balance, the use of amiodarone and a diagnosis of diabetes mellitus were independent predictors of the risk for falls. Thus, simple clinical data predicted falls better than objective functional tests.


Subject(s)
Aged , Female , Humans , Middle Aged , Accidental Falls/statistics & numerical data , Anticoagulants/therapeutic use , Atrial Fibrillation/complications , Stroke/prevention & control , Anticoagulants/adverse effects , Chronic Disease , Cross-Sectional Studies , Recurrence , Risk Assessment , Risk Factors
12.
Clinics ; 66(9): 1543-1548, 2011. ilus, tab
Article in English | LILACS | ID: lil-604290

ABSTRACT

OBJECTIVE: To verify whether the capacity of high-density lipoprotein (HDL) to simultaneously receive nonesterified cholesterol, triglycerides, cholesteryl esters, and phospholipids changes with aging and the presence of coronary artery disease. DESIGN: Cross-sectional study with biochemical analyses. SUBJECTS: Eleven elderly patients with coronary artery disease (74±5 years) were compared with the following groups of non-coronary artery disease subjects (referred to as "healthy"): 25 young (25±5 years), 25 middle-aged (42± years), and 25 elderly subjects (75±8 years). METHODS: Plasma samples were incubated with a nanoemulsion labeled with radioactive lipids; the transfer of the lipids from the nanoemulsion to the HDL was measured in chemically precipitated HDL. HDL size and paraoxonase-1 activity were also determined. RESULTS: The transfer of cholesteryl esters and phospholipids to high-density lipoprotein was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. Non-esterified cholesterol and triglyceride transfer was not different among these three groups. The HDL size was significantly greater (p<0.001) in healthy elderly subjects than in the middle-aged and younger subjects. The paraoxonase-1 activity was similar among the groups. Compared with healthy elderly subjects, coronary artery disease elderly subjects had significantly less (p<0.05) transfer of non-esterified cholesterol, triglycerides, and cholesteryl esters to the HDL and a significantly smaller (p<0.05) HDL size. CONCLUSION: Because lipid transfer is enhanced in healthy elderly subjects but not in those with coronary artery disease, increasing lipid transfer to HDL may be a protective mechanism against the disease.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Aging/blood , Cholesterol Esters/blood , Cholesterol, HDL/blood , Coronary Artery Disease/blood , Phospholipids/blood , Triglycerides/blood , Aryldialkylphosphatase/blood , Emulsions , Epidemiologic Methods , Nanoparticles , Particle Size
16.
Clinics ; 64(2): 135-142, 2009. graf, tab
Article in English | LILACS | ID: lil-505375

ABSTRACT

OBJECTIVES: To evaluate the prevalence of thyroid dysfunction in elderly cardiac patients in an outpatient setting. SUBJECTS AND METHODS: A total of 399 consecutive patients (268 women, age range 60-92 years) who were followed at Heart Institute were evaluated for thyroid dysfunction with serum free T4, TSH, anti-Peroxidase antibodies, urinary iodine excretion measurements and thyroid ultrasound. RESULTS: Hyperthyroidism (overt and subclinical) was present in 29 patients (6.5 percent), whereas hypothyroidism (overt and subclinical) was found in 32 individuals (8.1 percent). Cysts were detected in 11 patients (2.8 percent), single nodules were detected in 102 (25.6 percent), and multinodular goiters were detected in 34 (8.5 percent). Hashimoto's thyroiditis was present in 16.8 percent patients, most of whom were women (83.6 percent). The serum TSH increased with age and was significantly higher (p= <0.01) in patients, compared to the normal control group. No significant differences in serum TSH and free T4 values were observed when patients with atrial fibrillation (AF) where compared with those without arrhythmia. The median urinary iodine levels were 210 µg/L (40-856 µg/L), and iodine levels were higher in men than in women (p<0.01). Excessive iodine intake (urinary iodine >300 µg/L) was observed in one-third of patients (30.8 percent). CONCLUSIONS: Elderly patients have a higher prevalence of both hypo- and hyperthyroidism as well as thyroid nodules when compared with the general population. About one-third of the older patients had elevated urinary secretion of iodine and a higher prevalence of chronic Hashimoto's thyroiditis. It is recommended that ultrasonographic studies, tests for thyroid function and autoimmunity should be evaluated in elderly patients.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Cardiovascular Diseases/epidemiology , Hyperthyroidism/epidemiology , Hypothyroidism/epidemiology , Iodine/administration & dosage , Urban Population , Brazil/epidemiology , Cross-Sectional Studies , Cities/epidemiology , Hyperthyroidism , Hypothyroidism , Iodine/urine , Prevalence , Thyroid Function Tests , Thyrotropin/blood
17.
Arch. Clin. Psychiatry (Impr.) ; 36(supl.3): 83-87, 2009. tab
Article in Portuguese | LILACS | ID: lil-538484

ABSTRACT

OBJETIVO: Investigar a presença de transtornos psiquiátricos em pacientes com dor torácica de origem não cardíaca que não respondem aos tratamentos regulares. MÉTODO: Dezoito pacientes com dor torácica sem origem cardíaca e considerados por seus clínicos como não respondentes aos tratamentos regulares instituídos foram avaliados por um psiquiatra treinado. As entrevistas foram realizadas com base no Present State Examination e os diagnósticos psiquiá-tricos, de acordo com os critérios do Manual de Diagnóstico e Estatística da Associação Psiquiátrica Americana, 3ª Edição Revisada (DSM-III-R). RESULTADOS: Depressão maior no momento da avaliação foi diagnosticada em 6 (30 por cento) pacientes, somatização em 1 (6 por cento) e transtorno do pânico em 1 (6 por cento) paciente. Sete pacientes estavam recebendo antidepressivos tricíclicos com doses < 75 mg/dia. CONCLUSÕES: A baixa dose de ADTs usadas para o tratamento da dor nesses pacientes pode ter melhorado parcialmente os sintomas depressivos, tornando mais difíceis o diagnóstico e o tratamento apropriado(s) da depressão e, assim, contribuindo para a persistência da dor e outras queixas. As futuras pesquisas deverão focalizar a eficácia do tratamento da depressão nesses pacientes e o impacto deste no alívio da dor torácica não cardíaca.


OBJECTIVE: To investigate the presence of psychiatric disorders in patients with chest pain not responsive to treatment. METHOD: We evaluated 18 patients judged by their physicians to have a chest pain not responsive to usual treatment, which included anti-pain medicines and investigation and treatment of possible etiological causes such as coronary artery disease, and gastroesophageal reflux disease. A psychiatrist interviewed the patients using the Present State Examination and made the diagnosis based on the DSM-III-R criteria. Current major depression was diagnosed in 6 (30 percent) patients, somatization in 1 (6 percent) and panic disorder in 1 (6 percent) patient. Seven patients were receiving tricyclics antidepressant with doses > 75 mg/day. DISCUSSION: Patients were receiving doses of tricyclics antidepressants efficacious for pain but not for major depression. It is possible that the low dose of antidepressants used to treat pain may partially ameliorate depressive symptoms, making the appropriate diagnosis and treatment of major depression even more difficult, consequently contributing to the persistence of pain and other complains. Considering the wide alternatives to effectively treat depression, a focus on detection and treatment of major depression in patients with chest pain is warranted by clinicians and researchers.


Subject(s)
Primary Health Care , Depression/etiology , Chest Pain/therapy
18.
Arch. Clin. Psychiatry (Impr.) ; 36(supl.3): 88-92, 2009. ilus
Article in Portuguese | LILACS | ID: lil-538485

ABSTRACT

A associação entre transtorno depressivo maior e doenças cardiovasculares, em particular infarto agudo do miocárdio, é frequente, levando a pior prognóstico tanto da depressão como da doença cardiovascular, com maiores taxas de reinfarto e maior morbidade e mortalidade. Os autores discutem as evidências na literatura que demonstram essa associação entre infarto agudo do miocárdio e quadros depressivos, com enfoque nos avanços em fisiopatologia e terapêutica psiquiátrica. Vários estudos têm mostrado que o tratamento da depressão associada a quadros cardíacos é eficaz, melhora a qualidade de vida e pode ser feito com segurança. Embora o tratamento da depressão tenha sido associado à melhora de alguns parâmetros cardiovasculares, ainda não existem, entretanto, evidências de associação entre tratamento da depressão e melhora da morbidade e mortalidade cardiovascular.


The association between major depressive disorder and cardiovascular diseases, particularly myocardial infarction, is frequently observed, leading to worse prognosis both on the depressive disorder as well as cardiovascular disease, with increased rates of re-infarction and both morbidity and mortality. The authors review and discuss the evidence in the literature that supports the relationship between depressive disorder and cardiovascular disease, with focus on the advances on the physiopathology and the psychiatric management. Various studies have shown that treatment of depression is efficacious, improves quality of life and can be safely conducted. Although, treatment of depression has been associated with improvement on some cardiovascular parameters, there is no evidence so far that treatment of depression is associated with decrease of cardiovascular morbidity and mortality.


Subject(s)
Depression/psychology , Cardiovascular Diseases/etiology , Myocardial Infarction/physiopathology , Myocardial Infarction/psychology , Prognosis
20.
Rev. SOCERJ ; 19(4): 347-351, jul.-ago. 2006. ilus, graf
Article in Portuguese | LILACS | ID: lil-438646

ABSTRACT

O tratamento atual da doença coronariana crônica - angina estável, envolve o uso de medicamentos com ação hemodinâmica, como os nitratos, os betabloqueadores (BB) e os bloqueadores dos canais de cálcio (BCC). O presente artigo apresenta Ivabradina, um novo medicamento para a abordagem da angina estável, revisa o seu modo de ação e os resultados da literatura médica recente.


Subject(s)
Humans , Male , Female , Angina, Unstable/complications , Angina, Unstable/diagnosis , Atenolol/administration & dosage , Atenolol/adverse effects , Myocardial Infarction/complications , Myocardial Infarction/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL